Siga Technologies (SIGA) Change in Inventory (2012 - 2025)
Siga Technologies' (SIGA) quarterly Change in Inventory came in at $12.4 million in Q3 2025, up 94.79% on a YoY basis from $6.4 million in Q3 2024, and up 153.93% quarter-over-quarter from -$23.0 million in Q2 2025.
Analysis
Siga Technologies (SIGA) Change in Inventory (2012 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported Change in Inventory for 14 consecutive years, with $12.4 million the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, Change in Inventory rose 94.79% year-over-year to $12.4 million; the trailing twelve-month figure through Sep 2025 stood at -$13.8 million (down 305.48% YoY), and the FY2024 full-year result was -$15.3 million, down 160.11% from the prior year.
- Change in Inventory grew to $12.4 million in Q3 2025 per SIGA's latest filing, from -$23.0 million in the prior quarter.
- Across five years, Change in Inventory topped out at $14.8 million in Q3 2022 and bottomed at -$23.0 million in Q2 2025.
- Historically, Change in Inventory has averaged $1.5 million across 5 years, with a median of $176150.0 in 2022.
- The sharpest annual moves came in 2022 and 2023: Change in Inventory plunged 2238.33% in 2022, then jumped 4690.16% in 2023.
- Over 5 years, Change in Inventory stood at -$10.1 million in 2021, then jumped by 179.71% to $8.0 million in 2022, then plunged by 108.9% to -$715594.0 in 2023, then plunged by 1670.08% to -$12.7 million in 2024, then surged by 197.81% to $12.4 million in 2025.
- According to Business Quant data, Change in Inventory over the past three periods registered $12.4 million, -$23.0 million, and $9.5 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 571.00 Mn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 143.00 Mn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | - |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | - |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 11.88 Mn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 17.70 Mn |
| 10 | Siga Technologies | 235.60 Mn | 80.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 12.39 Mn |
| Jun 30, 2025 | -22.97 Mn |
| Mar 31, 2025 | 9.50 Mn |
| Dec 31, 2024 | -12.67 Mn |
| Sep 30, 2024 | 6.36 Mn |
| Jun 30, 2024 | -7.52 Mn |
| Mar 31, 2024 | -1.51 Mn |
| Dec 31, 2023 | -715,594.00 |
| Sep 30, 2023 | 14.50 Mn |
| Jun 30, 2023 | 8.44 Mn |
| Mar 31, 2023 | 3.30 Mn |
| Dec 31, 2022 | 8.04 Mn |
| Sep 30, 2022 | 14.84 Mn |
| Jun 30, 2022 | 176,150.00 |
| Mar 31, 2022 | -3.10 Mn |
| Dec 31, 2021 | -10.09 Mn |
| Sep 30, 2021 | 9.99 Mn |
| Jun 30, 2021 | -179,773.00 |
| Mar 31, 2021 | 144,852.00 |
| Dec 31, 2020 | 9.52 Mn |